International Archives of Allergy and Immunology · 2009 · 13 citations · 0 references
Life SciencesImmunologyInfectious DiseasesCell AdhesionClinical ImmunologyImmunopathologyAdhesion MoleculesCell Adhesion ReceptorsImmunodeficiency DisordersLeukocyte AdhesionAdhesion Molecule BiomarkersCellular Adhesion MoleculesControl Group DesignImmune Cell ActivationIntercellular Adhesion Molecule 1Matched Control Group
Cytopathic mechanisms in human immunodeficiency virus type 1 (HIV-1) infection involve syncytia formation, and it appears likely that increased expression of intracellular adhesion molecule 1 (ICAM-1) is involved in these cell adhesion phenomena. In this study, we determined serum concentrations of soluble ICAM-1 (sICAM-1) in 27 patients with HIV-1 infection and a control group. In addition, we compared sICAM-1 values to CD4+ T-cell counts, serum beta 2-microglobulin (beta 2M) and serum neopterin levels. HIV-1-infected patients had significantly higher sICAM-1, beta 2M and neopterin levels than controls. The subgroup of patients with Walter-Reed stages 3-6 had only slightly higher sICAM-1 concentrations in serum than Walter-Reed stages 1-2. The sICAM-1 concentrations in HIV-1-seropositive patients correlated with beta 2M levels but neither with neopterin nor with CD4+ T-cell counts. Increased sICAM-1 may result from immune activation, which enhances the expression of ICAM-1 in patients with HIV-1 infection.